Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci167672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Maria I Bergamasco und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Abnormalities, Multiple, Acetylcarnitine, Congenital Hypothyroidism, Craniofacial Abnormalities. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government, Victorian Government, Australian National Health and Medical Research Council.
Abstract (Originalsprache)
Mutations in genes encoding chromatin modifiers are enriched among mutations causing intellectual disability. The continuing development of the brain postnatally, coupled with the inherent reversibility of chromatin modifications, may afford an opportunity for therapeutic intervention following a genetic diagnosis. Development of treatments requires an understanding of protein function and models of the disease. Here, we provide a mouse model of Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) (OMIM 603736) and demonstrate proof-of-principle efficacy of postnatal treatment. SBBYSS results from heterozygous mutations in the KAT6B ( MYST4/MORF/QFK ) gene and is characterized by intellectual disability and autism-like behaviors. Using human cells carrying SBBYSS-specific KAT6B mutations and Kat6b heterozygous mice ( Kat6b +/– ), we showed that KAT6B deficiency caused a reduction in histone H3 lysine 9 acetylation. Kat6b +/– mice displayed learning, memory, and social deficits, mirroring SBBYSS individuals. Treatment with a histone deacetylase inhibitor, valproic acid, or an acetyl donor, acetyl-carnitine (ALCAR), elevated histone acetylation levels in the human cells with SBBYSS mutations and in brain and blood cells of Kat6b +/– mice and partially reversed gene expression changes in Kat6b +/– cortical neurons. Both compounds improved sociability in Kat6b +/– mice, and ALCAR treatment restored learning and memory. These data suggest that a subset of SBBYSS individuals may benefit from postnatal therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
- Department of Medical Biology and.
- Centre for Neurosciences of Speech, University of Melbourne, Parkville, Victoria, Australia.
- Redenlab Inc., Melbourne, Australia.
- School of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia.
- Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia.
Förderung
- Australian Government
- Victorian Government
- Australian National Health and Medical Research Council
Zitieren
APA
Bergamasco, M. I., Vanyai, H. K., Garnham, A. L., Geoghegan, N. D., Vogel, A. P., Eccles, S., Rogers, K. L., Smyth, G. K., Blewitt, M. E., Hannan, A. J., Thomas, T., & Voss, A. K. (2024). Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci167672
Vancouver
Bergamasco MI, Vanyai HK, Garnham AL, Geoghegan ND, Vogel AP, Eccles S, et al. Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice. Journal of Clinical Investigation. 2024. doi:10.1172/jci167672
BibTeX
@article{Bergamasco2024,
author = {Bergamasco, Maria I and Vanyai, Hannah K and Garnham, Alexandra L and Geoghegan, Niall D and Vogel, Adam P and Eccles, Samantha and Rogers, Kelly L and Smyth, Gordon K and Blewitt, Marnie E and Hannan, Anthony J and Thomas, Tim and Voss, Anne K},
title = {Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci167672}
}
EUVIMED